Next Day Disclosure Return
Filed with HKEX · Stock code 9966 · · 5 pages · English
Earlier from Alphamab Oncology
- Voluntary announcement - appointment of chief financial officer
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
- Voluntary announcement - IND approval by the FDA for a phase I clinical study of JSKN021
- Supplementary announcement on discloseable transaction
Follow Alphamab Oncology into a list and get an email when it puts out news.
Follow Alphamab Oncology